Cerebral vein thrombosis: from risk factors to recanalization and clinical outcomes. A review

Cover Page

Cite item

Full Text

Abstract

Cerebral vein thrombosis or cerebral venous thrombosis (CVT) is a complex venous thromboembolic disease with a different clinical picture, etiology and multiple potential complications. The frequency of occurrence is 0.5–1% of all stroke cases. Clinical symptoms occur as a result of increased intracranial pressure caused by a violation of venous outflow and brain damage. CVT is associated with a wide range of clinical symptoms from isolated headaches (the most common symptom on admission, registered in 90% of cases) to focal deficits, seizures and changes in mental status. Careful collection of anamnesis with targeted identification of risk factors, full-fledged diagnosis and treatment contribute to achieving a favorable clinical outcome in patients. The article focuses on the degree of recanalization of cerebral venous thrombosis, assessment of venous collaterals according to the degree of Qureshi and clinical outcomes depending on risk factors. These indicators are little studied at present.

About the authors

Tatiana Yu. Batenkova

Sverdlovsk Regional Clinical Hospital №1

Author for correspondence.
Email: tuska-9494@yandex.ru

neurologist

Russian Federation, Yekaterinburg

References

  1. Medicherla CB, Pauley RA, de Havenon A, et al. Cerebral Venous Sinus Thrombosis in the COVID-19 Pandemic. J Neuroophthalmol. 2020;40(4):457-62. doi: 10.1097/WNO.0000000000001122
  2. Amalia L. D-Dimer Level Associated with Amount of Sinus involvement Using Digital Subtraction Angiography on Cerebral Venous Thrombosis Patients. J Blood Med. 2023;14:303-8. doi: 10.2147/JBM.S399661
  3. Theologou R, Nteveros A, Artemiadis A, Faropoulos K. Rare Causes of Cerebral Venus Sinus Thrombosis: A Systematic Review. Life. 2023;13(5):1178. doi: 10.3390/life13051178
  4. Canedo-Antelo M, Baleato-González S, Mosqueira AJ, et al. Radiologic Clues to Cerebral Venous Thrombosis. Radiographics. 2019;39(6):1611-28. doi: 10.1148/rg.2019190015
  5. Wei H, Jiang H, Zhou Y, et al. Intracranial hypertension after cerebral venous thrombosis–Risk factors and outcomes. CNS Neurosci Ther. 2023;29(9):2540-7. doi: 10.1111/cns.14194
  6. Fan Y, Yu J, Chen H, et al. Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of cerebral venous sinus thrombosis. Stroke Vasc Neurol. 2020;5(2):152-8. doi: 10.1136/svn-2020-000358
  7. Silvis SM, de Sousa DA, Ferro JM, Coutinho JM. Cerebral venous thrombosis. Nat Rev Neurol. 2017;13(9):555-65. doi: 10.1038/nrneurol.2017.104
  8. Zenobia E, Lailiyya N, Dian S, et al. Platelet Selectin Levels in Patients with Cerebral Venous Sinus Thrombosis: Preliminary Findings. J Blood Med. 2023;14:359-65. doi: 10.2147/JBM.S405975
  9. Sader N, de Lotbinière-Bassett M, Tso MK, Hamilton M. Management of Venous Sinus Thrombosis. Neurosurg Clin N Am. 2018;29(4):585-94. doi: 10.1016/j.nec.2018.06.011
  10. Ulivi L, Squitieri M, Cohen H, et al. Cerebral venous thrombosis: a practical guide. Pract Neurol. 2020;20(5):356-67. doi: 10.1136/practneurol-2019-002415
  11. Zuurbier SM, Hiltunen S, Tatlisumak T, et al. Admission Hyperglycemia and Clinical Outcome in Cerebral Venous Thrombosis. Stroke. 2016;47(2):390-6. doi: 10.1161/STROKEAHA.115.011177
  12. Hung SH, Lin HC, Chung SD. Association between venous thromboembolism and iron-deficiency anemia: a population-based study. Blood Coagul Fibrinolysis. 2015;26(4):368-72. doi: 10.1097/MBC.0000000000000249
  13. Liu K, Song B, Gao Y, et al. Long-Term Outcomes in Patients with Anemia And Cerebral Venous Thrombosis. Neurocrit Care. 2018;29(3):463-8. doi: 10.1007/s12028-018-0544-6
  14. Azizi N, Maghbooli M, Rostami M, Kian S. Serum Levels of Ferritin, Iron, and TIBC in Cerebral Venous Sinus Thrombosis. Arch Neurosci. 2023;10(2). doi: 10.5812/ans-134857
  15. Barboza MA, Mejias C, Colin-Luna J, et al. Intracranial venous collaterals in cerebral venous thrombosis: clinical and imaging impact. J Neurol Neurosurg Psychiatry. 2015;86(12):1314-8. doi: 10.1136/jnnp-2014-309717
  16. Song S, Lan D, Wu XQ, Meng R. The clinical characteristic, diagnosis, treatment, and prognosis of cerebral cortical vein thrombosis: a systematic review of 325 cases. J Thromb Thrombolysis. 2021;51(3):734-40. doi: 10.1007/s11239-020-02229-x
  17. Duman T, Uluduz D, Midi I, et al. A Multicenter Study of 1144 Patients with Cerebral Venous Thrombosis: The VENOST Study. J Stroke Cerebrovasc Dis. 2017;26(8):1848-57. doi: 10.1016/j.jstrokecerebrovasdis.2017.04.020
  18. Lindgren E, Krzywicka K, de Winter MA, et al. A scoring tool to predict mortality and dependency after cerebral venous thrombosis. Eur J Neurol. 2023;30(8):2305-14.. doi: 10.1111/ene.15844
  19. Begley SL, White TG, Katz JM. Cerebral Venous Thrombosis: Medical Management vs. Endovascular Therapy. Curr Treat Options Neurol. 2023;25(8):1-17. doi: 10.1007/s11940-023-00752-9
  20. Huang P. Rare cause of cerebral venous sinus thrombosis: Spontaneous intracranial hypotension syndrome: A case report. World J Clin Cases. 2023;11(19):4677-83. doi: 10.12998/wjcc.v11.i19.4677
  21. Chen YC, Chang CW, Wu HC, et al. Clinical Characteristics and Prognostic Factors of Non-Infectious Cerebral Venous Sinus Thrombosis. J Clin Med. 2022;11(20):6096. doi: 10.3390/jcm11206096
  22. Pasricha SV, Bhayana R, Wu PE. Supine headache and papilledema: A case and review of cerebral venous sinus thrombosis. Clin Case Rep. 2023;11(5):e07329. doi: 10.1002/ccr3.7329
  23. Pongmoragot J, Saposnik G. Intracerebral Hemorrhage from Cerebral Venous Thrombosis. Curr Atheroscler Rep. 2012;14(4):382-9. doi: 10.1007/s11883-012-0260-1
  24. Coutinho JM, Zuurbier SM, Stam J. Declining Mortality in Cerebral Venous Thrombosis: A Systematic Review. Stroke. 2014;45(5):1338-41. doi: 10.1161/STROKEAHA.113.004666
  25. Sachdeva V, Nalawade R, Kannam M, et al. Clinical profile, diagnostic challenges, and outcomes in subacute/chronic cerebral sinus venous thrombosis. Indian J Ophthalmol. 2021;69(12):3598. doi: 10.4103/ijo.IJO_96_21
  26. Afifi K, Bellanger G, Buyck PJ, et al. Features of intracranial hemorrhage in cerebral venous thrombosis. J Neurol. 2020;267(11):3292-8. doi: 10.1007/s00415-020-10008-0
  27. Kumral E, Polat F, Uzunköprü C, et al. The clinical spectrum of intracerebral hematoma, hemorrhagic infarct, non-hemorrhagic infarct, and non-lesional venous stroke in patients with cerebral sinus-venous thrombosis: The clinical/neuroradiological spectrum of cerebral sinus-vein thrombosis. Eur J Neurol. 2012;19(4):537-43. doi: 10.1111/j.1468-1331.2011.03562.x
  28. Mahale R, Mehta A, John AA, et al. Acute seizures in cerebral venous sinus thrombosis: What predicts it? Epilepsy Res. 2016;123:1-5. doi: 10.1016/j.eplepsyres.2016.01.011
  29. Uluduz D, Midi I, Duman T, et al. Epileptic seizures in cerebral venous sinus thrombosis: Subgroup analysis of VENOST study. Seizure. 2020;78:113-7. doi: 10.1016/j.seizure.2020.02.017
  30. Ferro JM, Canhão P, Bousser MG, et al. Early Seizures in Cerebral Vein and Dural Sinus Thrombosis: Risk Factors and Role of Antiepileptics. Stroke. 2008;39(4):1152-8. doi: 10.1161/STROKEAHA.107.487363
  31. García-Azorín D, Monje MHG, González-García N, et al. Presence of red flags in patients with cerebral venous sinus thrombosis admitted to the emergency department because of headache: A STROBE compliant cohort-study. Medicine (Baltimore). 2020;99(29):e20900. doi: 10.1097/MD.0000000000020900
  32. Ferro JM, Bousser MG, Canhão P, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis – Endorsed by the European Academy of Neurology. Eur Stroke J. 2017;2(3):195-221. doi: 10.1177/2396987317719364
  33. Kharbat AF, Michel M, Morgan R, et al. Intracranial venous sinus thrombosis: Medical and surgical management considerations. BOHR Int J Neurol Neurosci. 2023;1(2):60-71. doi: 10.54646/bijnn.2023.09
  34. Herweh C, Griebe M, Geisbüsch C, et al. Frequency and temporal profile of recanalization after cerebral vein and sinus thrombosis. Eur J Neurol. 2016;23(4):681-7. doi: 10.1111/ene.12901
  35. Alimohammadi A, Kim DJ, Field TS. Updates in cerebral venous thrombosis. Curr Cardiol Rep. 2022;24(1):43-50. doi: 10.1007/s11886-021-01622-z
  36. Wasay M, Khan M, Rajput HM, et al. New Oral Anticoagulants versus Warfarin for Cerebral Venous Thrombosis: A Multi-Center, Observational Study. J Stroke. 2019;21(2):220-3. doi: 10.5853/jos.2019.00150
  37. Li H, Yao M, Liao S, et al. Comparison of Novel Oral Anticoagulants and Vitamin K Antagonists in Patients With Cerebral Venous Sinus Thrombosis on Efficacy and Safety: A Systematic Review. Front Neurol. 2020;11:597623. doi: 10.3389/fneur.2020.597623
  38. Lee GKH, Chen VH, Tan CH, et al. Comparing the efficacy and safety of direct oral anticoagulants with vitamin K antagonist in cerebral venous thrombosis. J Thromb Thrombolysis. 2020;50(3):724-31. doi: 10.1007/s11239-020-02106-7
  39. Nepal G, Kharel S, Bhagat R, et al. Safety and efficacy of Direct Oral Anticoagulants in cerebral venous thrombosis: A meta-analysis. Acta Neurol Scand. 2022;145(1):10-23. doi: 10.1111/ane.13506
  40. Esmaeili S, Abolmaali M, Aarabi S, et al. Rivaroxaban for the treatment of cerebral venous thrombosis. BMC Neurol. 2021;21(1):73. doi: 10.1186/s12883-021-02091-1
  41. Maqsood M, Imran Hasan Khan M, Yameen M, et al. Use of oral rivaroxaban in cerebral venous thrombosis. J Drug Assess. 2021;10(1):1-6. doi: 10.1080/21556660.2020.1838769
  42. Tektonidou MG, Andreoli L, Limper M, et al. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis. 2019;78(10):1296-304. doi: 10.1136/annrheumdis-2019-215213
  43. Dubey AK, Kalita J, Chaudhary SK, Misra UK. Impact of anticoagulation status on recanalization and outcome of cerebral venous thrombosis. J Clin Neurosci. 2021;89:43-50. doi: 10.1016/j.jocn.2021.04.016
  44. Gazioglu S, Eyuboglu I, Yildirim A, et al. Cerebral venous sinus Thrombosis: Clinical Features, Long-Term outcome and recanalization. J Clin Neurosci. 2017;45:248-51. doi: 10.1016/j.jocn.2017.07.028
  45. Zhao Y, Su X, Liu Z, et al. Effect of intracranial venous collaterals on neurological outcomes in cerebral venous thrombosis. J Clin Neurosci. 2022;102:95-100. doi: 10.1016/j.jocn.2022.06.009
  46. Ferro JM, Canhão P, Stam J, et al. Prognosis of Cerebral Vein and Dural Sinus Thrombosis: Results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35(3):664-70. doi: 10.1161/01.STR.0000117571.76197.26
  47. Ilyas A, Chen CJ, Raper DM, et al. Endovascular mechanical thrombectomy for cerebral venous sinus thrombosis: a systematic review. J NeuroInterventional Surg. 2017;9(11):1086-92. doi: 10.1136/neurintsurg-2016-012938
  48. Klein P, Shu L, Nguyen TN, et al. Outcome Prediction in Cerebral Venous Thrombosis: The IN-REvASC Score. J Stroke. 2022;24(3):404-16. doi: 10.5853/jos.2022.01606
  49. Liu L, Jiang H, Wei H, et al. Risk factors of impaired employability after cerebral venous thrombosis. CNS Neurosci Ther. 2023;29(4):1086-93. doi: 10.1111/cns.14083
  50. Rezoagli E, Martinelli I, Poli D, et al. The effect of recanalization on long-term neurological outcome after cerebral venous thrombosis. J Thromb Haemost. 2018;16(4):718-24. doi: 10.1111/jth.13954
  51. Shakibajahromi B, Haghighi AB, Salehi A, et al. Clinical and radiological characteristics and predictors of outcome of cerebral venous sinus thrombosis, a hospital-based study. Acta Neurol Belg. 2020;120(4):845-52. doi: 10.1007/s13760-018-1009-6
  52. Zhang Y, Liu Y, Qin B, et al. Characteristics of Poor Prognosis in Patients with Cerebral Venous Sinus Thrombosis: A Multicenter Retrospective Study. Neuropsychiatr Dis Treat. 2023;19:1417-26. doi: 10.2147/NDT.S414123
  53. Aguiar de Sousa D, Lucas Neto L, Arauz A, et al. Early Recanalization in Patients With Cerebral Ve- nous Thrombosis Treated With Anticoagulation. Stroke. 2020;51(4):1174-81. doi: 10.1161/STROKEAHA.119.028532
  54. Aguiar de Sousa D, Lucas Neto L, Canhão P, Ferro JM. Recanalization in Cerebral Venous Thrombosis: A Systematic Review and Meta-Analysis. Stroke. 2018;49(8):1828-35. doi: 10.1161/STROKEAHA.118.022129
  55. Arauz A, Vargas-González JC, Arguelles-Morales N, et al. Time to recanalisation in patients with cerebral venous thrombosis under anticoagulation therapy. J Neurol Neurosurg Psychiatry. 2016;87(3):247-51. doi: 10.1136/jnnp-2014-310068
  56. Karthik Vanukuri N, Pedapati R, Shanmugam S, et al. Effect of recanalization on clinical outcomes in patients with cerebral venous thrombosis – An ambispective study. Eur J Radiol. 2022;153:110385. doi: 10.1016/j.ejrad.2022.110385
  57. Nagaraja D. Recanalisation and outcome in cerebral venous-sinus thrombosis. Ann Indian Acad Neurol. 2022;25(2):177. doi: 10.4103/aian.aian_957_21
  58. Putaala J, Hiltunen S, Salonen O, et al. Recanalization and its correlation to outcome after cerebral venous thrombosis. J Neurol Sci. 2010;292(1-2):11-5. doi: 10.1016/j.jns.2010.02.017
  59. Ferro JM, Aguiar de Sousa D. Cerebral Venous Thrombosis: an Update. Curr Neurol Neurosci Rep. 2019;19(10):74. doi: 10.1007/s11910-019-0988-x
  60. Triquenot Bagan A, Crassard I, Drouet L, et al. Cerebral Venous Thrombosis: Clinical, Radiological, Biological, and Etiological Characteristics of a French Prospective Cohort (FPCCVT)–Comparison with ISCVT Cohort. Front Neurol. 2021;12:753110. doi: 10.3389/fneur.2021.753110
  61. Yaghi S, Shu L, Bakradze E, et al. Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study. Stroke. 2022;53(3):728-38. doi: 10.1161/STROKEAHA.121.037541
  62. Green M, Styles T, Russell T, et al. Non-genetic and genetic risk factors for adult cerebral venous thrombosis. Thromb Res. 2018;169:15-22. doi: 10.1016/j.thromres.2018.07.005

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Fig. 1. Diagnostic algorithm for the exclusion or confirmation of cerebral vein thrombosis.

Download (338KB)
Indexing metadata

Copyright (c) 2024 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies